 Outlook Therapeutics Inc NASDAQ:OTLK has announced financial results for its fiscal year ended September 30 and laid out plans for 2023 in an end-of-year letter. Our fiscal year 2022 laid a solid foundation for what we believe will be a transformational 2023, CEO Russell Trenary III said. 